insights_auto
Why is PTKFY up 5.13%?
Dive Deeperchevron_right
PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
$8.20
arrow_upward
+5.13%(+0.40) 1D
Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTKFY...
Open
$8.20
High
$8.20
Low
$8.20
Mkt. cap
35.34T
Avg. vol.
1.27K
Volume
626.00
52-wk high
$16.36
52-wk low
$7.63
Beta
0.09
Shares outstanding
234.07M
No. of employees
13K
Open
$8.20
High
$8.20
Low
$8.20
Mkt. cap
35.34T
Avg. vol.
1.27K
Volume
626.00
52-wk high
$16.36
52-wk low
$7.63
Beta
0.09
Shares outstanding
234.07M
No. of employees
13K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Kalbe Farma stock gets an IDR 500 billion buyback plan for 2026
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Unsponsored Indonesia ADR